Emerging medtech companies to watch
Healthcare innovation is increasingly being driven by agile, research-led Medtech companies addressing critical clinical and operational challenges.
R&D Partners has created this platform to spotlight emerging businesses developing impactful technologies across the healthcare ecosystem. These founder presentations offer investors direct insight into the teams, technologies, and market opportunities influencing the future of medical innovation.
Andreas Hartlep, CEO of Sooma Medical
Expanding access to drug free neurostimulation therapies
Sooma Medical develops non-invasive neurostimulation therapies designed to support depression and chronic pain treatment through clinically validated, drug-free technology.
Samu Lehtonen, CEO of Marginum
Advancing real-time cancer tissue detection in surgery
Marginum develops fluorescence-guided surgical technology that helps clinicians detect cancerous tissue in real time, improving surgical precision and patient outcomes.
Bob Enck, CEO & Chairman of ProtonDx LTD
Transforming point-of-care molecular diagnostics
ProtonDx develops portable molecular diagnostic devices enabling rapid, accurate detection of infectious diseases at the point of need using advanced lab-on-chip technology.
Maria Leiloglou, CEO of Enacuity
Advancing surgical imaging with AI driven enhancement
Enacuity develops AI-powered imaging software that enhances surgical visuals in real time, enabling better identification of critical structures without additional hardware.
Waleed Faisal, CEO & Founder of ArrayPatch
Advancing drug delivery with microneedle technology
ArrayPatch develops microneedle-based drug delivery technology designed to improve treatment effectiveness across dermatology and chronic conditions through a scalable and minimally invasive platform.
Arnau Garriga Casanovas, CEO & Founder of Serpenta
Transforming GI surgery with soft robotics
Serpenta is developing advanced soft robotic systems designed to enable precise, minimally invasive procedures in lower GI surgery through flexible, next-generation endoluminal technology.
Peter Coates, Managing Director of Apperta Foundation
Scaling open digital health platforms
Apperta Foundation develops open digital health platforms that enable better data sharing, supporting improved patient outcomes and more efficient, connected healthcare systems
Cormac Farrelly, Co-founder & CMO of LaNua Medical
Advancing precision in embolization therapy
LaNua Medical develops image-guided technologies for minimally invasive embolization procedures, enabling more precise blood flow control and targeted therapy delivery.
Joanne Lant, Founder & CEO of Lant Medical
A new approach to H. pylori treatment
Lant Medical is developing a non-antibiotic treatment for H. pylori, aiming to improve gastrointestinal care while reducing dependence on traditional antibiotic therapies.
Paul Christie, Chief Executive Officer of Tachmed
Scaling connected diagnostics with AI-driven insights
Tachmed develops connected diagnostic solutions that combine at-home testing devices with cloud-based data and AI to enable faster, more accessible healthcare insights..